SecBot SecBot
8-K ·Filed Oct 30, 2026

GRDX

GridAI Technologies Corp.
NEUTRAL
Impact 2/10
Horizonmonths Processed18d 1h ago SEC0001104659-26-120725
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

The RSU vesting milestone tied to filing audited financials of an acquired business signals a potential pending acquisition. Monitor for a definitive acquisition agreement and subsequent 8-K/A filing, which would trigger 50,000 RSUs vesting and provide details on the transaction.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$4.79
T+0 close · Oct 30, 2026 · via day close
Latest settled
+11.69%
T+5 · $5.35 · next T+20 in 14d
Vs SPY
+11.61%
α at T+5
Latest observation
−23.67%
T+9 · FF3 residual α
  1. T+0 · Nov 2 $4.79entry
  2. T+1 · 14d ago +0.84%α +0.54% · $4.83
  3. T+5 · 8d ago +11.69%α +11.61% · $5.35
  4. T+11 · todayOpen
  5. T+20 · in 14d Pending
  6. T+60 · in 2mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

GridAI Technologies Corp. filed an 8-K reporting Amendment No. 4 to the CFO Consulting Agreement with BPC Consulting Ltd., under which Anna Skowron serves as Interim CFO. The amendment, effective September 1, 2026, sets a fixed monthly retainer of $27,000, eliminates hourly overtime billing, and grants up to 250,000 RSUs with a vesting schedule tied to continued service and a milestone related to an acquisition. The agreement runs through August 31, 2027 with automatic renewal. This is a routine compensatory arrangement for an existing interim officer, not a departure or appointment.

Key Facts

  • Amendment No. 4 to CFO Consulting Agreement effective September 1, 2026, filed October 26, 2026.
  • Anna Skowron continues as Interim CFO via BPC Consulting Ltd.
  • Fixed monthly retainer set at $27,000, invoiced in two equal installments.
  • Hourly rate and overtime billing provisions from Amendment No. 2 are eliminated.
  • Up to 250,000 RSUs granted: 75,000 vested immediately on September 1, 2026; 25,000 on December 31, 2026; 50,000 upon filing of an 8-K/A with audited financials of an acquired business; and 25,000 on each of March 31, June 30, September 30, and December 31, 2027.
  • All unvested RSUs accelerate upon a Change of Control, excluding a specific potential acquisition under evaluation.
  • Term runs through August 31, 2027, with automatic one-year renewals.
  • Company may terminate with six months notice or immediately for Cause; termination other than for Cause with less than six months notice triggers payment in lieu of notice.
  • Consultant eligible for discretionary annual cash bonus and potential additional RSU grants in 2027.

Financial Impact

Monthly cash retainer of $27,000; up to 250,000 RSUs granted with immediate vesting of 75,000 RSUs (approximately 0.18% of market cap at $41M market cap, assuming $0.10 per share).

cash compensationdilution

Risk Factors

  • Potential dilution from up to 250,000 RSUs, though immaterial relative to current market cap.
  • Automatic renewal provision reduces company flexibility to non-renew without cause.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-120725
Document: tm2628544d1_10-1.htm0001104659-26-120725
Document: 0001104659-26-120725-index-headers.html0001104659-26-120725
Document: 0001104659-26-120725-index.html0001104659-26-120725
Document: 0001104659-26-120725.txt0001104659-26-120725

Track record

15 reports on GRDX

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +39.11% at T+20 after the Jul 9, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 17, 2026today 8-K Mixed 7/10 Entry price pending
  2. Nov 13, 20264d ago Press Release Neutral 5/10 Entry $3.74 to $3.30 Now $3.30 −11.76% ▼ −11.76% −9.85% vs SPY
  3. Oct 30, 202618d ago 8-K Neutral 2/10 Viewing Entry $4.79 to $4.83 Now $3.30 −31.11% ▲ +0.84% +0.54% vs SPY
  4. Oct 28, 202620d ago 8-K Neutral 4/10 Entry $5.45 to $4.96 Now $3.30 −39.45% ▼ −8.99% −7.22% vs SPY
  5. Oct 28, 202620d ago 8-K Bearish 6/10 Entry $5.45 to $4.96 Now $3.30 +39.45% ▲ +8.99% +7.22% vs SPY
  6. Oct 23, 202625d ago 8-K Neutral 2/10 Entry $5.55 to $5.84 Now $3.30 −40.54% ▲ +5.14% +4.57% vs SPY
  7. Oct 20, 202628d ago EFFECT Mixed 6/10 Entry $4.63 to $4.90 Now $3.30 −28.73% ▲ +5.83% +5.31% vs SPY
  8. Oct 7, 20265w ago 8-K Neutral 3/10 Entry $4.80 to $4.97 Now $3.30 −31.25% ▲ +3.54% +2.94% vs SPY
  9. Oct 6, 20266w ago S-1/A Bearish 7/10 Entry $4.12 to $4.80 Now $3.30 +19.90% ▼ −16.50% −16.93% vs SPY
  10. Aug 24, 202612w ago S-1/A Bearish 7/10 Entry $3.65 to $4.06 Now $3.30 +9.59% ▼ −11.23% −10.91% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026